Wikisage, the free encyclopedia of the second generation, is digital heritage
Iscador: Difference between revisions
Jump to navigation
Jump to search
(todo) |
(rfz4) |
||
| Line 2: | Line 2: | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133960/ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients] | ||
</ref> | </ref> | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124023/ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis]</ref> | |||
<references/> | <references/> | ||
Revision as of 15:28, 5 December 2015
Mistletoe (Iskador mali) a preparation of Viscum album L.) off-label. Since decades Mistletoe has been used in European medicine for oncology[1]Mistletoe lectins (e.g. Iscador Q viscotoxin) have been identified as main active components and exhibit cytotoxic effects as well as immunomodulatory activity[2] [3] [4]
- ↑ Safety of Intravenous Application of Mistletoe (Viscum album L.) Preparations in Oncology: An Observational Study
- ↑ Fermented Mistletoe Extract as a Multimodal Antitumoral Agent in Gliomas
- ↑ Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients
- ↑ Quality of Life and Related Dimensions in Cancer Patients Treated with Mistletoe Extract (Iscador): A Meta-Analysis